Search clinical trials for: ProQuad

Total 40 results

Merck Sharp & Dohme LLC

Completed

ProQuad® Intramuscular vs Subcutaneous

Measles | Rubella | Mumps | Varicella
Medical University of South Carolina

Completed

Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant (ProQuad®)

RENAL INSUFFICIENCY, CHRONIC | LIVER FAILURE, ACUTE | HEART DISEASE

United States
Merck Sharp & Dohme LLC

Completed

Safety Study of ProQuad® rHA in Infants (V221-037)

Measles | Rubella | Mumps | Varicella
University of Basel
Senevita AG

Completed

Improving Pain Management in Nursing Homes: a Pilot Study (ProQuaS)

Pain Management

Switzerland
Merck Sharp & Dohme LLC

Completed

Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)

Measles | Hepatitis A | Rubella | Mumps | Chickenpox
Merck Sharp & Dohme LLC

Completed

A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038)

Measles | Rubella | Mumps | Varicella
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

Measles-Mumps-Rubella

Taiwan, United States, Korea, Republic of
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

Hepatitis B | Measles | Pertussis | Rubella | Mumps | Tetanus | Diphtheria | Varicella | Poliomyelitis | Haemophilus Infections

Germany, Italy
Merck Sharp & Dohme LLC

Completed

V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

ProQuad Dose Selection Study (V221-011)(COMPLETED)

Measles | Rubella | Mumps | Varicella
Washington University School of Medicine
National Institute on Minority Health and Health Disparities (NIMHD); University...

Recruiting

Efficacy of a Multi-level School Intervention for LGBTQ Youth

Depression | Anxiety | Post Traumatic Stress Disorder | Substance Use | Coping Behavior | Suicidality | Bullying | Sexual Minority Stress | Harassment

United States
University of Southern California

Completed

Feasibility of a Multi-Level School Intervention for LGBTQ Youth

Sexual Minority Stress Experiences Among LGBTQ Youth

United States
Merck Sharp & Dohme LLC

Completed

Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Terminated

A Study of ProQuad™ in Healthy Children in Korea (V221-023)

Measles | Rubella | Mumps | Varicella
MCM Vaccines B.V.
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)

Virus Diseases | Bacterial Infections
University of Ulm
Center for Military Mental Health, Berlin, Germany; Illinois Institute of Technology...

Recruiting

Honest, Open, Proud for Soldiers With Mental Illness

Mental Illness

United States, Germany
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age

Measles | Rubella | Mumps | Varicella

United States
Merck Sharp & Dohme LLC

Completed

ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)

Measles | Rubella | Mumps | Varicella
RAND
Dfusion Inc.

Completed

Interventions to Improve Reproductive Health Among Adolescents

Teacher Training

United States
Oslo University Hospital
University of Oslo

Recruiting

Honest Open Proud for Psychotic and Bipolar Disorder in Norway (HOP-NOR)

Psychotic Disorders | Bipolar Disorder | Disclosure

Norway
University of Ulm
Illinois Institute of Technology, Chicago, USA; Child and Adolescent Psychiatry... and other collaborators

Completed

Honest Open Proud for Adolescents With Mental Illness

Secrecy Versus Disclosure Among Adolescents With Mental Illness

United States, Germany
Mathematica Policy Research, Inc.
Office of Population Affairs

Completed

Evaluation of the Making Proud Choices! Teen Pregnancy Prevention Program

Teen Pregnancy Prevention
RAND

Unknown

Enhancing Quality Interventions Promoting Healthy Sexuality (EQUIPS)

HIV | Pregnancy in Adolescence

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers

Measles | Rubella | Mumps | Varicella | Meningococcal Meningitis

United States, Puerto Rico
Qilu Hospital of Shandong University

Recruiting

A Prospective, Single-centre，Single-blinded Study of PROUD for Prostate Carcinoma Diagnosis

Prostate Carcinoma

China
Academisch Medisch Centrum - Universiteit van Amsterdam...
Nano4Imaging GmbH; Brightfish

Recruiting

New MRI Techniques for Diagnosis and Treatment of Abdominal Aortic Aneurysms (MARVY)

Abdominal Aortic Aneurysm Without Rupture

Netherlands
Pacific Institute for Research and Evaluation
National Institute of Mental Health (NIMH)

Completed

A School-Based HIV/STD Prevention Program to Reduce Risky Sexual Behaviors Among Adolescents in Liberia

HIV Infections

Liberia
Merck Sharp & Dohme LLC

Completed

Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)

Hepatitis A Virus
Sanofi Pasteur, a Sanofi Company

Completed

Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

Measles | Rubella | Mumps | Varicella | Meningococcal Meningitis

United States, Chile
GlaxoSmithKline

Recruiting

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

Measles; Mumps; Rubella; Chickenpox

United States
Kaiser Permanente
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial (PROUD)

Opioid-use Disorder

United States
Brooke Army Medical Center
InterMune

Completed

Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin

Hepatitis C

United States
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH)

Completed

Training Community Members to Deliver HIV Prevention Programs to Urban Youth

HIV Infections | HIV

United States
Ottawa Hospital Research Institute

Completed

REaCT Integrated Consent Model to Compare Two Standard of Care Regimens (OTT14-03)

Breast Cancer

Canada
Novartis Vaccines

Completed

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

Meningitis, Meningococcal

United States, Argentina, Colombia
University of Sao Paulo
Rio de Janeiro State University; Santa Catarina Federal University; Iguaçu University

Active, not recruiting

Non-instrumentation Root Canal Treatment of Primary Molars (EndoDecide-1)

Dental Pulp Diseases | Dental Pulp Necrosis

Brazil
Institut de Myologie, France
Aparito Ltd.

Recruiting

Feasibility, Validation and Application of Digital Tools for the Follow-up of Neuromuscular Patient Mobility in Daily Living (DT4RD)

Neuromuscular Diseases

France, United Kingdom

Search clinical trials for: ProQuad

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations